See Why Sonnet BioTherapeutics Stock Is Skyrocketing In Premarket Tuesday
Arrowhead's ARO-HIF2 Shows Early Signs Of Efficacy In Type Of Kidney Cancer
Merck's Keytruda Shows Clinical Benefit in Post-Surgery Kidney Cancer Setting
Merck's Keytruda Shows Better Disease-Free Survival As Adjuvant Therapy In Kidney Cancer
Kidney Cancer Recent News
Merck's Belzutifan Wins Priority Review Status In Type Of Kidney Cancer
Aveo Pharma's Tivozanib To Be Tested In Combination With Opdivo In Kidney Cancer
Aveo Pharma's Stock Trading Higher On Much Awaited FDA Approval For Tivozanib In Relapsed Kidney Cancer
European Medicines Agency's CHMP Backs Approval Of Cabometyx/Opdivo Combo In Kidney Cancer
Merck/Eisai's Keytruda-Lenvima Combo Tops Standard Of Care In Late-Stage Kidney Cancer Study
Exelixis' Cabozantinib Data Shows Clinically Significant Benefit Versus Pfizer's Sutent, In A Type Of Kidney Cancer